Regulatory activity over the past week reflected steady committee throughput in Europe, a targeted oncology decision in the USA, and a cluster of safety and supply updates in the UK, Canada and ...
US pharma company Esperion Therapeutics has entered into an agreement to acquire Corstasis Therapeutics, a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results